Thursday, February 5, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Starbucks A Success Story of Growth and Returns

Elaine Mendonca by Elaine Mendonca
February 23, 2024
in Breaking News
0
DrugRetailers Stock Bull Market
0
SHARES
3
VIEWS
Share on FacebookShare on Twitter

Starbucks has demonstrated remarkable performance over the past 15 years, surpassing the market with an average annual return of 22.87%. Imagine if someone had invested $100 in SBUX stock 15 years ago – it would now be valued at $2,104.81, based on the current price of $95.87 per share. The company’s market capitalization is currently at $108.55 billion.

The success of Starbucks can be credited to its effective management team, which prioritizes returning profits to shareholders through dividends and share repurchases. Their global expansion strategy, aiming for 55,000 stores worldwide, and their ability to generate revenue from their brand have all contributed to their growth.

Analysts have set a 12-month price target for Starbucks at $200.00. As of February 22, 2024, Starbucks’ total return over the past ten years has been an impressive 226.95%. The stock is currently trading close to its 52-week low, making it a potentially attractive investment opportunity for those seeking long-term growth.

Starbucks Corporation (SBUX) Sees Positive Movement in Stock Performance on February 23, 2024

On February 23, 2024, Starbucks Corporation (SBUX) saw some positive movement in its stock performance. The coffee giant’s shares opened at $95.88, which was $0.10 higher than its previous close. Throughout the trading day, SBUX experienced a price increase of $0.24, resulting in a 0.25% rise in its stock value.

Investors and analysts will be closely monitoring SBUX’s performance in the coming days to see if this positive movement can be sustained. The company’s financial health, strategic initiatives, and overall market conditions will all play a role in determining the future trajectory of SBUX’s stock price.

Starbucks Corporation Reports Strong Financial Performance in Past Year and First Quarter of Current Fiscal Year

On February 23, 2024, Starbucks Corporation (SBUX) reported its financial performance for the past year and the first quarter of the current fiscal year. According to data from CNN Money, the coffee giant generated a total revenue of $35.95 billion over the past year, with $9.42 billion coming in the first quarter. This represents an 11.55% increase in total revenue compared to the previous year, but total revenue remained flat compared to the previous quarter.

In terms of net income, Starbucks reported a total of $4.12 billion for the past year, with $1.02 billion in the first quarter. This represents a 25.69% increase in net income compared to the previous year, but a 15.98% decrease compared to the previous quarter.

Earnings per share (EPS) also saw positive growth, with Starbucks reporting an EPS of $3.58 for the past year and $0.90 in the first quarter. This represents a 26.47% increase in EPS compared to the previous year, but a 15.34% decrease compared to the previous quarter.

Overall, Starbucks’ financial performance over the past year has been strong, with significant increases in total revenue, net income, and earnings per share. However, the slight decrease in performance compared to the previous quarter may have impacted investor sentiment on February 23, 2024.

Investors and analysts will likely closely monitor Starbucks’ future performance to see if the company can sustain its growth trajectory and continue to deliver strong financial results. As always, it is important for investors to conduct thorough research and analysis before making any investment decisions.

Tags: SBUX
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Finances (2)

Analyst Downgrades Sunnova Energy Intl NYSENOVA with Lower Price Target

Healthcare-sector

Guardant Health Inc Reports Strong FourthQuarter Sales and Optimistic Outlook for 2024

Analyst Initiates Coverage on ORIC Pharmaceuticals with Overweight Rating

Recommended

SKYX Platforms Stock

Marriott Partnership Signals Major Breakthrough for SKYX Platforms

5 months ago
Microsoft Stock

Microsoft’s AI Ambition: A High-Stakes Bet on Future Growth

18 hours ago
Turtle Beach Stock

Turtle Beach Forges PlayStation Alliance with New Gaming Headset

5 months ago
FLO stock news

Cemtrex Shares Surge After Halting Trading Due to Circuit Breaker

2 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

CureVac Delisted Following BioNTech Acquisition Completion

Strategic Robotics Partnership Signals New Growth Phase for EOS Defence

NexPoint Residential Trust Sets Date for Annual and Q4 2025 Results

PC Connection Set to Report Full-Year and Fourth Quarter Earnings

Fossil Group Stock Surges Past Key Technical Threshold

NextGen Healthcare: Strategic Wins and Industry Accolades Signal Sustained Momentum

Trending

Rolls Royce Stock
Defense & Aerospace

Rolls-Royce Shares: A Pivotal Period for Growth and Diversification

by Dieter Jaworski
February 5, 2026
0

The coming weeks represent a critical juncture for Rolls-Royce. The company is poised to demonstrate whether it...

Viking Therapeutics Stock

Viking Therapeutics: Investors Await Key Clinical Updates in Forthcoming Report

February 5, 2026
Solana Stock

Solana Faces Billions in Potential Token Supply Releases

February 5, 2026
CureVac Stock

CureVac Delisted Following BioNTech Acquisition Completion

February 5, 2026
EOS Stock

Strategic Robotics Partnership Signals New Growth Phase for EOS Defence

February 5, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Rolls-Royce Shares: A Pivotal Period for Growth and Diversification
  • Viking Therapeutics: Investors Await Key Clinical Updates in Forthcoming Report
  • Solana Faces Billions in Potential Token Supply Releases

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com